专利信息

首页 1 2 尾页共 13 条记录, 当前第1/2页。

专利标题：PROCESS FOR PREPARATION OF TAFLUPROST AND INTERMEDIATES THEREOF

A method for synthesis of tafluprost and intermediates thereof are provided. The method involves hydroxyl-protecting reaction using a boronate ester, boronic acid or aminoborane as a reagent, carbonyl-oxidizing reaction, and hydroxyl-deprotecting reaction.

专利标题：PROCESS FOR THE PREPARATION OF TAFLUPROST AND INTERMEDIATES THEREOF

The present invention provides efficient, economical and environmental friendly methods for synthesis of prostaglandin analogs including tafluprost and intermediates thereof. The invention involves a selective oxidation using in situ boronate ester protection and a unique crystallization method to remove the undesired isomers of fluorinated intermediates.

专利标题：Process for the preparation of tafluprost and intermediates thereof

The present invention provides efficient economical and environmental friendly methods for synthesis of prostaglandin analogs including tafluprost and intermediates thereof. The invention involves a selective oxidation using in situ boronate ester protection and a unique crystallization method to remove the undesired isomers of fluorinated intermediates.

专利标题：A kind of novel method of synthetic tafluprost

专利标题：Combination of sulfonamide compound and tafluprost

The object of the present invention is to discover a combination of preventive or therapeutic drugs for glaucoma or ocular hypertension which is useful as a preventive or therapeutic agent for glaucoma or ocular hypertension. By combining isopropyl(6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate with tafluprost their intraocular pressure lowering effects are complemented and/or enhanced each other. As for the administration form these drugs may be administe...

专利标题：COMBINATION OF SULFONAMIDE COMPOUND AND TAFLUPROST

The object of the present invention is to discover a combination of preventive or therapeutic drugs for glaucoma or ocular hypertension, which is useful as a preventive or therapeutic agent for glaucoma or ocular hypertension. By combining isopropyl(6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate with tafluprost, their intraocular pressure lowering effects are complemented and/or enhanced each other. As for the administration form, these drugs may be admini...

专利标题：AMINE SALTS OF PROSTAGLANDIN ANALOGS

专利权人：REDDYS LAB LTD DR [IN];

The present application relates to amine salts of prostaglandin analogs and their uses for the preparation of substantially pure prostaglandin analogs. Specific embodiments relate to amine salts of tafluprost and their uses for the preparation of substantially pure tafluprost.

专利标题：Kosmetische Zusammensetzung, enthaltend Tafluprost, Cyclodextrin und Hyaluronsäure

专利权人：S & V TECHNOLOGIES AG [DE];

Kosmetische Zusammensetzung, enthaltendTafluprost 0,002-0,0018 Gew.-% Wässrige Pufferlösung > 90 Gew.-% Cyclodextrin 0,0015-0,5 Gew.-% Hyaluronsäure oder Hyaluronsäuresalz 0,1-3 Gew.-% Konservierungsmittel < 1.5 Gew.-%

专利标题：Tafluprost et ses dérivés pharmaceutiquement acceptables (saflutan®)

专利权人：Santen Pharmaceutical Co. Ltd.;

专利标题：Hair growth promoting agent containing 15,15-difluoroprostaglandin F2alpha derivative as active ingredient

当前查询条件: [药品] 包含 'Tafluprost'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. WO2014023256A1	2014/2/13	WO2013CN81125	2013/8/9
专利标题：PROCESS FOR PREPARATION OF TAFLUPROST AND INTERMEDIATES THEREOF 专利权人：SCINOPHARM CHANGSHU PHARMACEUTICALS LTD [CN]; A method for synthesis of tafluprost and intermediates thereof are provided. The method involves hydroxyl-protecting reaction using a boronate ester, boronic acid or aminoborane as a reagent, carbonyl-oxidizing reaction, and hydroxyl-deprotecting reaction.

2. US2014046086A1	2014/2/13	US201313962058	2013/8/8
专利标题：PROCESS FOR THE PREPARATION OF TAFLUPROST AND INTERMEDIATES THEREOF 专利权人：SCINOPHARM CHANGSHU PHARMACEUTICALS LTD [CN]; The present invention provides efficient, economical and environmental friendly methods for synthesis of prostaglandin analogs including tafluprost and intermediates thereof. The invention involves a selective oxidation using in situ boronate ester protection and a unique crystallization method to remove the undesired isomers of fluorinated intermediates.

3. US20140046086A1	2014/2/13
专利标题：Process for the preparation of tafluprost and intermediates thereof 专利权人：Scinopharm (changshu) Pharmaceuticals, Ltd.; The present invention provides efficient economical and environmental friendly methods for synthesis of prostaglandin analogs including tafluprost and intermediates thereof. The invention involves a selective oxidation using in situ boronate ester protection and a unique crystallization method to remove the undesired isomers of fluorinated intermediates.

4. CN103570549A	2014/2/12
专利标题：A kind of novel method of synthetic tafluprost 专利权人：

5. US20140018350A1	2014/1/16
专利标题：Combination of sulfonamide compound and tafluprost 专利权人：Santen Pharmaceutical Co., Ltd.;asahi Glass Co., Ltd.; The object of the present invention is to discover a combination of preventive or therapeutic drugs for glaucoma or ocular hypertension which is useful as a preventive or therapeutic agent for glaucoma or ocular hypertension. By combining isopropyl(6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate with tafluprost their intraocular pressure lowering effects are complemented and/or enhanced each other. As for the administration form these drugs may be administe...

6. US2014018350A1	2014/1/16	US201313939437	2013/7/11
专利标题：COMBINATION OF SULFONAMIDE COMPOUND AND TAFLUPROST 专利权人：ASAHI GLASS CO LTD [JP];SANTEN PHARMA CO LTD [JP]; The object of the present invention is to discover a combination of preventive or therapeutic drugs for glaucoma or ocular hypertension, which is useful as a preventive or therapeutic agent for glaucoma or ocular hypertension. By combining isopropyl(6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate with tafluprost, their intraocular pressure lowering effects are complemented and/or enhanced each other. As for the administration form, these drugs may be admini...

7. WO2013118058A1	2013/8/15	WO2013IB50976	2013/2/6
专利标题：AMINE SALTS OF PROSTAGLANDIN ANALOGS 专利权人：REDDYS LAB LTD DR [IN]; The present application relates to amine salts of prostaglandin analogs and their uses for the preparation of substantially pure prostaglandin analogs. Specific embodiments relate to amine salts of tafluprost and their uses for the preparation of substantially pure tafluprost.

8. DE202012003193U1	2012/4/30	DE20122003193U	2012/3/29
专利标题：Kosmetische Zusammensetzung, enthaltend Tafluprost, Cyclodextrin und Hyaluronsäure 专利权人：S & V TECHNOLOGIES AG [DE]; Kosmetische Zusammensetzung, enthaltendTafluprost 0,002-0,0018 Gew.-% Wässrige Pufferlösung > 90 Gew.-% Cyclodextrin 0,0015-0,5 Gew.-% Hyaluronsäure oder Hyaluronsäuresalz 0,1-3 Gew.-% Konservierungsmittel < 1.5 Gew.-%

9. LU91943I2	2012/4/16
专利标题：Tafluprost et ses dérivés pharmaceutiquement acceptables (saflutan®) 专利权人：Santen Pharmaceutical Co. Ltd.;

10. CN102143753A	2011/8/3	CN20098134648	2009/9/4
专利标题：Hair growth promoting agent containing 15,15-difluoroprostaglandin F2alpha derivative as active ingredient 专利权人：SANTEN PHARMA CO LTD;ASAHI GLASS CO LTD;

下载范围

下载内容